Related Experiment Video
Updated: Apr 6, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes
Thomas Tousseyn1, Krystyna Bajsarowicz, Henry Sánchez
1From the Department of Pathology (Neuropathology) (TT, KB, HS, AG, AO, BD, SJD), Department of Neurology (MG), Memory and Aging Center (MG), and Institute for Neurodegenerative Diseases (SJD), University of California San Francisco, San Francisco, California.
Prion disease (PrionD) can trigger Alzheimer disease (AD)-like changes, including beta-amyloid (Aβ) and tau pathology. Scrapie-associated prion protein (PrP) and APOE-4 may drive neuron loss in PrionD.
Area of Science:
- Neuroscience
- Neuropathology
- Biochemistry
Background:
- Prion diseases (PrionD) and Alzheimer disease (AD) are distinct neurodegenerative disorders.
- Overlap in pathological changes between PrionD and AD suggests potential shared mechanisms.
Purpose of the Study:
- To investigate mechanistic links between PrionD and AD.
- To determine if PrionD can induce AD-like pathology, specifically beta-amyloid (Aβ) and tau.
- To explore the role of scrapie-associated prion protein (PrP) and apolipoprotein E-4 (APOE-4) in PrionD-associated neurodegeneration.
Main Methods:
- Analysis of brain tissue from 266 patients with PrionD and 6 controls.
- In vitro exposure of human brain aggregates (BrnAggs) to Creutzfeldt-Jakob disease (CJD) brain homogenate.
- Western blot analysis to quantify Aβ42 levels.
- Immunohistochemical examination of hippocampal CA1 regions for PrP, Aβ42, APOE-4, and hyperphosphorylated tau (Hτ).
Main Results:
- 17% of PrionD patients exhibited AD-like changes.
- CJD-infected BrnAggs produced abundant intraneuronal Aβ42 inclusions, unlike controls.
- Western blots confirmed higher Aβ42 levels in CJD-infected aggregates.
- Hippocampal analysis revealed distinct patient subgroups based on PrP and Aβ42 levels, with high PrP and APOE-4 correlating with significant neuron loss.
- Both PrionD and AD groups showed increased Hτ pathology.
Conclusions:
- Prion disease can induce biochemical changes mirroring those in Alzheimer disease.
- PrionD pathogenesis involves PrP, Aβ42, APOE-4, and abnormal tau.
- The findings suggest PrionD may act as a trigger for AD-like pathology.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation

